What does a “Provera challenge” test for?
A “Provera challenge” is a short course of the hormone medroxyprogesterone acetate (Provera) used to see whether the uterus can respond to progesterone. Clinicians use it as a screening step when someone has irregular or absent periods (amenorrhea) to help distinguish between causes of bleeding problems.
If withdrawal bleeding happens after the Provera course, it usually suggests the uterus is working and that estrogen is present at some level. If no withdrawal bleeding occurs, it points more toward either insufficient estrogen effect, problems with the outflow tract/uterus, or other causes that prevent bleeding.
What conditions does it help differentiate?
The Provera challenge is typically used in workups that separate “anovulation or low estrogen” causes from “outflow/uterine” causes of amenorrhea. It often comes up in evaluation for:
- Hypothalamic or pituitary causes (low signaling to the ovaries), which can reduce estrogen.
- Ovarian causes (including some forms of ovarian dysfunction), which can also reduce estrogen.
- Uterine outflow issues where withdrawal bleeding cannot occur even if hormone pathways are intact.
How is a Provera challenge usually done?
Protocols vary by clinician, but the typical approach is:
- Take medroxyprogesterone (Provera) for a defined number of days.
- Then stop it and watch for “withdrawal bleeding” after the medication ends.
The presence or absence of bleeding guides the next diagnostic steps.
What happens after the results come back?
If withdrawal bleeding occurs, clinicians generally shift toward evaluating ovulation/function (for example, whether cycles are irregular because ovulation is not happening regularly). If withdrawal bleeding does not occur, clinicians usually proceed to additional hormone testing and possibly imaging to evaluate for estrogen deficiency and other structural or outflow causes.
How does this relate to pregnancy and other urgent considerations?
A common early step before any hormone challenge is to rule out pregnancy, because pregnancy and pregnancy-related bleeding patterns can mimic amenorrhea/abnormal bleeding presentations. If pregnancy is possible, a clinician typically orders a pregnancy test first.
Are there medication risks or side effects?
Provera (medroxyprogesterone acetate) can cause expected progestin-related effects such as bloating, breast tenderness, mood changes, and breakthrough spotting. Risks and suitability depend on the person’s medical history (for example, clotting risk, liver disease, and other contraindications a clinician would consider).
Do you mean a clinical test or “Provera challenge” as a question about treatment?
“Provera challenge” is often discussed as a diagnostic test, but people sometimes use the phrase in the context of giving Provera to induce a period. The clinical meaning depends on the exact goal: diagnostic differentiation versus inducing withdrawal bleeding. If you share what led to the question (amenorrhea duration, any hormone test results, age, and whether pregnancy was ruled out), I can tailor what the test is trying to determine and what the usual next steps are.